NCT06529367

Brief Summary

This study aims to compare a home vision self-assessment test to office-based Snellen visual acuity in myopic children.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 31, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

July 31, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

August 1, 2024

Status Verified

July 1, 2024

Enrollment Period

6 months

First QC Date

July 27, 2024

Last Update Submit

July 31, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Agreement of visual acuity between office and home

    Agreement of visual acuity between office and home will be assessed.

    immediately after test performing

Study Arms (1)

Visual Acuity Testing group

Home vision assessment will be conducted using the "Letter Distance Chart" PDF document, a modified Early Treatment of Diabetic Retinopathy Study (ETDRS) chart for testing at 5 or 10 feet, and released for public use. Patients will be asked to use the 5-foot distance for standardization, which allows for visual acuity assessment from 20/16 to 20/200. Patients will be asked to wear their current corrective lens for distance, to take the test at home in a place with good lighting, and to test each eye separately. Office-based vision testing will be performed by a trained ophthalmic technician in a dimmed room with the Snellen chart illuminated on a screen. Patients will be asked to wear their current corrective lens for distance and an eye occluder will be used to test each eye separately.

Other: Snellen chart

Interventions

Patients will be asked to use the 5 feet distance for standardization, which allows for visual acuity assessment from 20/16 to 20/200. Patients will be asked to wear their current corrective lens for distance, to take the test at home in a place with good lighting and to test each eye separately. Office-based vision testing will be performed by a trained ophthalmic technician in a dimmed room with the Snellen chart illuminated on a screen. Patients will be asked to wear their current corrective lens for distance and an eye occluder will be used to test each eye separately.

Visual Acuity Testing group

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This cross-sectional study will be carried out on 80 myopic children aged ≤ 18 years, who completed the home visual acuity test and have a subsequent office-based VA test at South Valley University for a period from July 2024 to January 2025 after approval from the institutional ethical committee.

You may qualify if:

  • Age ≤ 18 years.
  • Both sexes.
  • Patients who completed the home visual acuity test and have a subsequent office-based visual acuity test.

You may not qualify if:

  • Last in-office visual acuity of 20/125 or worse in both eyes (to allow for a buffer of at least 2 lines of vision from the upper limit of 20/200 on the home vision assessment).
  • Lack of access to MyChart.
  • History of keratopathy, cataract, glaucoma, retinal detachment, neuro-ophthalmic disease, or other eye diseases.
  • History of ophthalmic surgery or trauma.
  • History of systemic diseases.
  • Severe psychological or psychiatric diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Valley University

Qina, 83523, Egypt

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Ophthalmology, Faculty of Medicine, South Valley University, Qena, Egypt.

Study Record Dates

First Submitted

July 27, 2024

First Posted

July 31, 2024

Study Start

July 31, 2024

Primary Completion

February 1, 2025

Study Completion

February 1, 2025

Last Updated

August 1, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations